ScopeStream pairs an AI-assisted digital pathology scanner with a remote pathologist review network — so slides get reviewed faster, by the right specialist. Tell us which side you’re on.
For pathologists
A flexible way to review remotely — take on cases around your existing commitments, help clear reporting backlogs, and earn for the reviews you complete.
You’re on the list
We’ll contact you as the founding reviewer network takes shape.
For labs & hospitals
Pathologist shortages, growing slide backlogs, slow turnaround and the rising cost of outsourced reviews — ScopeStream is being built to take that pressure off your lab.
Indicative pricing — India
₹35,000 / device
Covers up to 5,000 tests — no per-test cost.
*Indicative pricing, subject to change.
Thanks — you’re on the list
Thanks for sharing where your lab is at — it directly helps us validate demand and build the right thing. We’ll be in touch as ScopeStream launches.
An AI-assisted digital pathology scanner paired with a network of remote pathologists — so slides can be digitised and reviewed by the right specialist, wherever they are.
Glass slides are scanned into high-resolution digital images on the ScopeStream scanner, which is designed to be straightforward and affordable to run in a routine lab.
Digitised slides can be shared securely for remote review and integrated with your existing systems through digital-pathology connectivity solutions such as Vivalution.
Flexible, remote review that fits around your existing commitments, with reviewers paid for the cases they complete. We’re finalising the details together with our founding reviewers — which is exactly why we’d like to hear from you now.
We’re still shaping the commercial model, which is why the sign-up form asks what you’d expect to pay. We’ll share pricing with interested labs as we get closer to launch.
ScopeStream is built on validated science. The technology is backed by a 28-patent portfolio — spanning device design, ML models, algorithms and engineering — and four peer-reviewed publications across clinical-AI algorithms, performance evaluation and system architecture (in venues including IEEE and ML4H). The device is CDSCO-approved in India and designed for CE readiness in developed markets.
Protecting patient data is central to how we’re building ScopeStream, and we’ll meet the data-protection requirements of the markets we operate in. The details you submit here are used only to contact you about ScopeStream — we won’t share or sell them.